Clinical trial • Gastroenterology

Clinical trial in Anal fistula associated with Crohn's disease

Clinical trial for Anal fistula associated with Crohn's disease. 48 participants.

Overview

Trial Therapeutic Area
Gastroenterology
Trial Disease
Anal fistula associated with Crohn's disease
Drug Modality
Cell therapy

Key dates

Initial CTIS Submission Date
22-01-2025
First CTIS Authorization Date
30-01-2025

Trial design

Clinical trial across 2 sites in Poland.

Target Sample Size
48

Eligibility

Recruits 48 Vulnerable population not selected; no special consent or assent handling described in the record..

Vulnerable Population
Vulnerable population not selected; no special consent or assent handling described in the record.

Recruitment

Planned Sample Size
48
Recruitment Window Months
37

Geography

Total Number Of Sites
2
Total Number Of Participants
48

Poland

Earliest CTIS Part Ii Submission Date
24-01-2025
Latest Decision Or Authorization Date
11-03-2026
Processing Time Days
411
Number Of Sites
2
Number Of Participants
48

Sites

Site Name
Szpital Specjalistyczny Im. Ludwika Rydygiera W Krakowie Sp. z o.o.
Department Name
Oddział Kliniczny Chirurgii Ogólnej i Onkologii
Principal Investigator Name
Piotr Wałęga
Principal Investigator Email
piotr.walega@uj.edu.pl
Contact Person Name
Piotr Wałęga
Site Name
5 Wojskowy Szpital Kliniczny Z Poliklinika Samodzielny Publiczny Zaklad Opieki Zdrowotnej W Krakowie
Department Name
Klinika Chirurgii Ogólnej i Onkologicznej
Contact Person Name
Michał Nowakowski
Contact Person Email
mcwbk@5wszk.com.pl

Sponsor

Primary sponsor

Full Name
Uniwersytet Jagiellonski Collegium Medicum
Organisation Type
Educational Institution
Country Of Registered Address
Poland

Related trials

Other published trials that may interest you.